Relapsed or refractory diffuse large B-cell Lymphoma CAR-T Cell Therapy is superior to Standard Second-line Therapy

被引：0
|
作者：
Ruedesheim, Sabine M.
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [21] Single-Center Experience of Axicabtagene Ciloleucel CAR-T Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma
    Melody, Megan
    Rahman, Zaid Abdel
    Ernesto, Ayala
    Gannon, Nicole
    Roy, Vivek
    Sher, Taimur
    Ailawadhi, Sikander
    Foran, James
    Dabaja, Mohamed Kharfan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S267 - S268
  • [22] CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
    Kinoshita, Hannah
    Bollard, Catherine M.
    Toner, Keri
    SEMINARS IN HEMATOLOGY, 2023, 60 (05) : 329 - 337
  • [23] Unresolved questions in the second-line use of CAR-T cells for diffuse large B cell lymphoma
    Cliff, Edward R. Scheffer
    Merryman, Reid W.
    Armand, Philippe
    Jacobson, Caron A.
    NATURE MEDICINE, 2022, 28 (12) : 2458 - 2459
  • [24] Unresolved questions in the second-line use of CAR-T cells for diffuse large B cell lymphoma
    Edward R. Scheffer Cliff
    Reid W. Merryman
    Philippe Armand
    Caron A. Jacobson
    Nature Medicine, 2022, 28 : 2458 - 2459
  • [25] Anti-CD19 chimeric antigenic receptor T cell as a second-line therapy for patients with relapsed/refractory diffuse large B-cell lymphoma.
    Naqvi, Syed Arsalan Ahmed
    Asghar, Noureen
    Sipra, Qurat Ul Ain Riaz
    Paludo, Jonas
    Bin Riaz, Irbaz
    Husnain, Muhammad
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] Characterization of Hemophagocytic Lymphohistio(HLH)in Relapsed Diffuse Large B-Cell Lymphoma Patients after CAR-T Therapy
    Zhou, Lili
    Ye, Shiguang
    Dang, Xiuyong
    Li, Shaoguang
    Li, Ping
    BLOOD, 2023, 142
  • [27] CAR T-cell therapy in diffuse large B-cell lymphoma
    Hopfinger, Georg
    Worel, Nina
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 32 - 35
  • [28] CAR T-cell therapy in diffuse large B-cell lymphoma
    Georg Hopfinger
    Nina Worel
    memo - Magazine of European Medical Oncology, 2020, 13 : 32 - 35
  • [29] CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope
    Hopfinger, Georg
    Jaeger, Ulrich
    Worel, Nina
    HEMASPHERE, 2019, 3 (02):
  • [30] CAR-T Treatment: Determining the Survival Gain in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
    Messori, Andrea
    Damuzzo, Vera
    Leonardi, Luca
    Agnoletto, Laura
    Chiumente, Marco
    Mengato, Daniele
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (07): : 490 - 491
12345